Switch to:
More From Other Websites
VIVUS Acquires Certain Topamax Related Patents from J&J Aug 26 2014
Traders look for rebound in Vivus Aug 26 2014
VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals Aug 25 2014
Vivus acquires patent rights to Qsymia ingredient Aug 25 2014
Vivus acquires patent rights to Qsymia ingredient Aug 25 2014
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 25 2014
VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals Aug 25 2014
7:00 am Vivus announced the acquisition of a group of patents from Janssen Pharmaceuticals (Aug 25 2014
You've got obesity all wrong: Zafgen CEO Aug 19 2014
[video] Obesity treatment sales fall short Aug 18 2014
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 15 2014
VIVUS INC Financials Aug 15 2014
VIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Aug 12 2014
VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales Aug 08 2014
Vivus Inc Earnings Call scheduled for 4:30 pm ET today Aug 07 2014
VIVUS Reports Second Quarter 2014 Financial Results Aug 07 2014
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 07 2014
VIVUS Reports Second Quarter 2014 Financial Results Aug 07 2014
Q2 2014 Vivus Inc. Earnings Release - After Market Close Aug 07 2014
VIVUS Announces Date of Second Quarter 2014 Update and Financial Results Conference Call Jul 31 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK